☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - December 2019

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Prasterone (Intrarosa®) has been rejected for use in the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms. The manufacturer did not make a submission to the SMC and as such it cannot be recommend.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - December 2019' by emailShare 'SMC Update - December 2019' on FacebookShare 'SMC Update - December 2019' on TwitterShare 'SMC Update - December 2019' on LinkedInShare 'SMC Update - December 2019' on reddit


No Comments to “SMC Update - December 2019”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.